MEIP - MEI Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Total Revenue
4,544
4,915
1,622
23,249
0
Cost of Revenue
3,594
4,263
3,383
5,000
-
Gross Profit
950
652
-1,761
18,249
-
Operating Expenses
Research Development
34,346
32,300
17,038
7,237
13,403
Selling General and Administrative
15,700
14,597
9,787
8,628
5,667
Total Operating Expenses
50,046
46,897
26,825
15,865
21,004
Operating Income or Loss
-49,096
-46,245
-28,586
2,384
-21,004
Total Other Income/Expenses Net
9,987
27,632
-9,705
-
-
Income Before Tax
-37,512
-16,818
-40,067
2,671
-20,861
Income Tax Expense
-
1
1
1
1
Income from Continuing Operations
-37,513
-16,819
-40,068
2,670
-20,862
Net Income
-37,513
-16,819
-40,068
2,670
-20,862
Net Income available to common shareholders
-37,513
-16,819
-40,068
2,670
-20,862
Basic EPS
-
-0.24
-0.97
0.07
-0.61
Diluted EPS
-
-0.75
-0.97
0.07
-0.61
Basic Average Shares
-
71,139
41,431
36,813
34,400
Diluted Average Shares
-
72,385
41,431
36,938
34,400
EBITDA
-
-46,165
-28,533
2,469
-20,946